Codexis appoints Sriram Ryali as CFO; Ross Taylor steps down

CODEXIS, INC.

Sriram Ryali appointed CFO effective Jan 23, 2023; previously CFO at Eiger BioPharmaceuticals.
Ross Taylor ceased as CFO and principal accounting officer; no disagreement; will advise until Mar 6.
Ryali receives $450K base salary, 50% target bonus, $100K sign-on bonus (repayable if leave <1 yr).
Option grant valued ~$1.33M (Black-Scholes) and performance stock units $667K based on 2023 goals.
Severance: 12 months base salary (non-CIC) or 18 months salary + full equity acceleration (CIC).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sriram Ryali

Chief Financial Officer

CDXS · CODEXIS, INC.

Effective: 2023-01-23
Filed: January 23, 2023, 6:59 PM ET

On January 23, 2023, Codexis, Inc. (the “Company” or “Codexis”) announced the appointment of Sriram Ryali, M.B.A., as the Company’s Chief Financial Officer and principal financial and accounting officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sriram Ryali was appointed as Chief Financial Officer at CODEXIS, INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 23, 2023, Codexis, Inc. (the “Company” or “Codexis”) announced the appointment of Sriram Ryali, M.B.A., as the Company’s Chief Financial Officer and principal financial and accounting officer, effective immediately.

View on SEC.gov

CODEXIS, INC. filing history →

Source: SEC EDGAR

accession 0001200375-23-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.